Gastrointestinal Complications in Critically III Patients: The Intensivists' Overview

The American Journal of Gastroenterology

Volumn 81, Issue 4, 1986, Pages 227-238

  Gottlieb, Jonathan E ^a   Menashe, Phillip I ^a   Cruz, Edwin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANGIOTENSIN; ANTACID AGENT; ANTIHISTAMINIC AGENT; ARBAPROSTIL; BENZODIAZEPINE DERIVATIVE; CAPTOPRIL; CARBENOXOLONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; DIGOXIN; DOPAMINE; GROWTH HORMONE; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; ISOPRENALINE; METARAMINOL; METHOXAMINE; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYGEN; PENTAGASTRIN; PHENYLEPHRINE; PROPRANOLOL; PROSTAGLANDIN E2; RETINOL; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT;

ADVERSE DRUG REACTION; CARDIOVASCULAR SYSTEM; CHOLECYSTITIS; CONFUSION; DIAGNOSIS; DIGESTIVE SYSTEM; GALLBLADDER; GASTRITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; GASTROSCOPY; HEART; HEART FAILURE; HUMAN; INTENSIVE CARE; INTESTINE INFARCTION; INTESTINE ISCHEMIA; INTOXICATION; JAUNDICE; LARGE INTESTINE; LIVER; LIVER FAILURE; LIVER TOXICITY; NERVOUS SYSTEM; NEUROTOXICITY; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SEPSIS; SHOCK; SMALL INTESTINE; STOMACH; STOMACH ACID SECRETION; STOMACH ULCER; STRESS ULCER; SURVEY;

ANIMAL; ANTACIDS; CHOLECYSTITIS; CIMETIDINE; CRITICAL CARE; GASTRIC ACID; GASTROINTESTINAL DISEASES; HUMAN; INFECTION; INTESTINES; ISCHEMIA; LIVER CIRCULATION; LIVER DISEASES; PEPTIC ULCER; SHOCK; SPLANCHNIC CIRCULATION; STRESS;

EID: 0022495660     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1986.tb01470.x     Document Type: Review

References (93)

1. Acute erosions and stress ulcer
2. Relationship between ulceration and intramural pH of gastric mucosa during hemorrhagic shock
3. On acute ulceration of the duodenum in cases of burns
4. Peptic ulcers and the interbrain
5. Natural history and surgical dilemma of “stress” gastric bleeding
6. Prospective study of gastric secretion in stressed patients with intracranial injury
7. Acute haemorrhagic gastritis: modern concepts based on pathogenesis
8. The gastric mucosal barrier: clinical and experimental studies in critically ill and normal man, and in the rabbit
9. Retardation of acid diffusion by pig gastric mucus: a potential role in mucosal protection
10. Gastric mucosal energy metabolism and “stress ulceration
11. Studies on the pathogenesis of “stress ulcer”: effect of hemorrhage, transfusion and vagotomy in the restrained rat
12. Influence of isoproteienol and cholestyramine on acute gastric mucosal ulcerogenesis
13. Hypoxia of canine gastric mucosa caused by escherichia coli sepsis and prevented with methylprednisolone therapy
14. Water immersion restraint stress inhibits epithelial proliferation in rat gastric fun‐dus
15. Pentagastrin protects against stress ulceration in rats
16. Prevention of stress ulcerations with cimetidine and carbenoxolone
17. Prevention of stress ulcers
18. Decreased incidence of restraint‐stress induced gastric erosions in rats treated with bovine growth hormone
19. Predictive value of intramural pH and other risk factors for massive bleeding from stress ulceration
20. Increased gastrin release following penetrating central nervous system injury
21. H2‐receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure
22. Destruction of the gastric mucosal barrier by detergents and urea
23. Upper gastrointestinal bleeding in patients with chronic renal failure
24. Acute gastoduodenal disease after thermal injury
25. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis
26. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit
27. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit
28. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit
29. Gastrointestinal hemorrhage in patients in a respiratory intensive care unit
30. Gastric acidity in the comatose patient
31. 15 (R)‐15‐methyl prostaglandin E2 does not prevent gastrointestinal bleeding in seriously ill patients
32. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients
33. Methods of prophylaxis in stress ulcer disease
34. Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill
35. Gastric pH monitoring as a prognostic indicator for the prophylaxis of stress ulceration in the critically ill
36. Failure of cimetidine prophylaxis in the critically ill
37. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill
38. Cimetidine: prophylaxis against upper gastrointestinal haemorrhage after renal transplantation
39. Control of gastric pH with cimetidine: boluses versus primed infusions
40. Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury
41. Antacid versus cimetidine in preventing acute gastrointestinal bleeding
42. Antacid control of complications from acute gastroduodenal disease after burns
43. Antacid titration in the prevention of acute gastrointestinal bleeding
44. A consideration of the adverse effects of cimetidine
45. Reactive hepatopathy
46. Bacterial infection as a cause of jaundice
47. Liver function in septic shock
48. Jaundice in severe bacterial infection
49. Cholestatic effects of escherichia coli endotoxin on the isolated perfused rat liver
50. Vascular response in the isolated rat liver. I. Endotoxin, direct effect
51. Influence of endotoxin administration on hepatic function of rats with altered endotoxin sensitivity
52. +, K+‐adenosinetriphosphatase by endotoxIn: a possible mechanism for endotoxin‐induced cholestasis
53. Jaundice associated with nonhepatic Slaphviococciis aureus infection
54. Marked elevation in serum alkaline phosphatase activity as a manifestation of systemic infection
55. Mechanism of hepatic dysfunction following shock and trauma
56. Continuous positive‐pressure ventilation and portal flow in dogs with pulmonary edema
57. Hepatic cell integrity in hypodynamic states
58. Cardiac and noncardiac forms of acute circulatory failure (shock)
59. Biochemical and immunological characterization of human opsonic α2SB glycoprote In: its identity with cold‐insoluble globulin
60. Humoral factor depletion and reticuloendothelial depression during hemorrhagic shock
61. Humoral deficiency and reticuloendothelial depression after traumatic shock
62. The circulation and the liver
63. Hepatic physiologic and morphologic alterations in hemorrhagic shock
64. The shock liver
65. Ischemic hepatitis
66. Left‐sided heart failure presenting as hepatitis
67. Extreme elevation of transaminase levels in acute heart disease—a problem in differential diagnosis
68. Congestive heart failure as a cause of fulminant hepatic failure
69. Shock liver
70. Acute acalculous cholecystitis
71. Acalculous cholecystitis in critically ill patients
72. Continuous positive‐pressure ventilation and choledochoduodenal flow resistance
73. Empyema of the gallbladder—potential consequence of medical intensive care
74. Infarction of the bowel in cardiac failure
75. Ischemic intestinal syndromes
76. Intestinal blood flow
77. Reactive hyperemia and oxygen extraction in the feline small intestine
78. The effects of hypercapnia and hypoxia on the distribution of capillary blood flow in the denervated intestinal vascular bed
79. The relationship between summated tissue respiration and metabolic rate in mouse and dog
80. Effect of solute‐coupled volume absorption on oxygen consumption in the cat ileum
81. Combined effect of exercise and digestion on hemodynamics in conscious dogs
82. The vagal control of jejunal and ileal motility and blood flow
83. Cardiovascular effects of some commonly‐used pressor amines
84. Effects of angiotensin, vasopressin and methoxzamine on cardiac function and blood flow distribution in conscious dogs
85. Control of the splanchnic circulation in man
86. The effect of digoxin in the splanchnic circulation in ventricular failure
87. Factors other than major vascular occlusion that contribute to intestinal infarction
88. Cardiac arrhythmias and their termination. Their effect on systemic hemodynamics and the coronary, superior mesenteric and renal circulations
89. Mesenteric vascular insufficiency: intestinal ischemia induced by remote circulatory disturbances
90. Response of the intestinal mucosa to ischemia
91. Effect of intraluminal oxygen on experimental ischaemia of the intestine
92. Intestinal ischemia: reduction of mortality utilizing intraluminal perfluorochemical